Helsinn Integrative Care Gains FDA Clearance for Xonrid Gel
Helsinn Integrative Care has received FDA marketing clearance for Xonrid gel which is used for radiotherapy-induced dermatitis.
It is recognized in the EU as a medical device, so the FDA acknowledges it as a device too.
The product is intended to be used for less than 30 days and not on open wounds. — Cynthia Jessup